• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION DYNAGEN X4 CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G158
Device Problems Pacing Problem (1439); Inappropriate/Inadequate Shock/Stimulation (1574); Unexpected Therapeutic Results (1631)
Patient Problem Electric Shock (2554)
Event Date 11/21/2020
Event Type  malfunction  
Manufacturer Narrative
If additional information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) delivered 6 inappropriate shocks and bursts of anti tachycardia pacing (atp) due to suspected atrial driven rhythms.Sustained rate duration (srd) feature timed out and did not inhibit inappropriate therapy.The episode was isolated but therapy was exhausted.Boston scientific technical services reviewed episode and recommended further review with physician.Therapy delivery is considered inappropriate as this device is not intended to treat atrial arrhythmias.This device remains in service.No additional adverse patient effects were reported.
 
Manufacturer Narrative
This supplemental report was filled to correct field h6: "device codes.".
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) delivered 6 inappropriate shocks and bursts of anti tachycardia pacing (atp) due to suspected atrial driven rhythms.Sustained rate duration (srd) feature timed out and did not inhibit inappropriate therapy.The episode was isolated but therapy was exhausted.Boston scientific technical services reviewed episode and recommended further review with physician.Attempts to obtain more information on this case were unsuccessful.Therapy delivery is considered inappropriate as this device is not intended to treat atrial arrhythmias.This device remains in service.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DYNAGEN X4 CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key11136445
MDR Text Key225755613
Report Number2124215-2020-27727
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526534904
UDI-Public00802526534904
Combination Product (y/n)N
PMA/PMN Number
P010012/S341
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/07/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/05/2019
Device Model NumberG158
Device Catalogue NumberG158
Device Lot Number168804
Was Device Available for Evaluation? No
Date Manufacturer Received11/21/2020
Patient Sequence Number1
Patient Age64 YR
-
-